ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer Guidelines
| Authors: | Gennari, A.; André, F.; Barrios, C. H.; Cortés, J.; de Azambuja, E.; DeMichele, A.; Dent, R.; Fenlon, D.; Gligorov, J.; Hurvitz, S. A.; Im, S. A.; Krug, D.; Kunz, W. G.; Loi, S.; Penault-Llorca, F.; Ricke, J.; Robson, M.; Rugo, H. S.; Saura, C.; Schmid, P.; Singer, C. F.; Spanic, T.; Tolaney, S. M.; Turner, N. C.; Curigliano, G.; Loibl, S.; Paluch-Shimon, S.; Harbeck, N.; on behalf of the ESMO Guidelines Committee |
| Title: | ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer |
| Keywords: | treatment; germline; diagnosis; metastatic breast cancer; endocrine therapy; double-blind; brca mutation; reported outcomes; open-label; trastuzumab emtansine; international consensus guidelines; physicians choice; escat; esmo clinical practice guideline; esmo-mcbs; alpelisib plus fulvestrant; sacituzumab; govitecan |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | 12 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-12-01 |
| Start Page: | 1475 |
| End Page: | 1495 |
| Language: | English |
| ACCESSION: | WOS:000721610600008 |
| DOI: | 10.1016/j.annonc.2021.09.019 |
| PROVIDER: | wos |
| PUBMED: | 34678411 |
| Notes: | Article -- Source: Wos |
